Desmoid tumors are rare, noncancerous tumors that can develop in the connective tissues of the body. Desmoid tumors can occur anywhere in the body, but they are most commonly found in the abdomen, chest, and neck. These tumors can cause pain, swelling, and a mass that can be felt under the skin. Treatment for desmoid tumors can be challenging. In this article, we will explore the latest treatments for desmoid tumors and discuss the risks and benefits of each.
Desmoid tumors are classified as either sporadic or familial. Sporadic desmoid tumors are those that occur randomly and are not associated with any specific inherited genetic mutation. Familial desmoid tumors are those that occur in individuals who have a family history of the condition.
The diagnosis of desmoid tumors is made based on a physical examination, imaging studies, and biopsy. Treatment of desmoid tumors is based on the location, size, and type of tumor. The goal of treatment is to reduce the tumor size and prevent it from spreading.
Surgery is the most commonly used treatment for desmoid tumors. Surgery may be used to remove the entire tumor or to reduce the size of the tumor. Depending on the size and location of the tumor, the surgeon may be able to remove the tumor without damaging nearby tissues. In some cases, the surgeon may need to remove part of a nearby organ or tissue to remove the tumor.
Radiation therapy is another treatment option for desmoid tumors. Radiation therapy is used to shrink the tumor and reduce the risk of recurrence. It is usually used in combination with surgery. The radiation is delivered in small doses over a period of time.
Chemotherapy is a treatment option for desmoid tumors that are not responding to other treatments. Chemotherapy drugs are used to kill cancer cells and shrink tumors. The drugs are usually given intravenously or orally.
Targeted therapy is a newer treatment option for desmoid tumors. This type of therapy uses drugs that target specific molecules on the surface of the tumor cells. These drugs can block the growth and spread of the tumor.
All treatments for desmoid tumors have risks and benefits. Surgery and radiation therapy can cause side effects such as pain, swelling, and infection. Chemotherapy and targeted therapy can cause side effects such as nausea, vomiting, and fatigue. The benefits of treatment for desmoid tumors include reducing the size of the tumor, preventing it from spreading, and reducing the risk of recurrence. Treatment can also reduce pain and improve quality of life.
Desmoid tumors are rare, noncancerous tumors that can occur anywhere in the body. Treatment for desmoid tumors can be challenging. Surgery, radiation therapy, chemotherapy, and targeted therapy are all treatment options for desmoid tumors. Each treatment has risks and benefits, and it is important to discuss these with your doctor before starting treatment. With the latest treatments, it is possible to reduce the size of the tumor and improve quality of life.
1.
Psychedelic Therapy Tied to Reduced Depression, Anxiety.
2.
New drug resistance mechanism in melanoma leptomeningeal disease revealed by study.
3.
Research finds stark disparities in treatment and survival time for people with pancreatic cancer
4.
Tumor characteristics found to differ for melanomas in children, teens and young adults
5.
Relationship-building key to addressing oncologist shortages in rural care
1.
Artificial Intelligence in Oncology: Current Trends, Challenges and Future Outlook
2.
Colon cancer: Risk factors, warning signs and treatment options
3.
Exploring the Latest Advances in Hodgkin's Lymphoma Treatment
4.
Can We Repurpose BV-CHP for Better Outcomes in Peripheral T-Cell Lymphoma?
5.
The Expanding Horizon of PSMA: A Comparative Clinical Review of Theranostics in Prostate Cancer and Beyond
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
Navigating the Brain Barrier: The CNS Challenge in ALK+ NSCLC
2.
Efficient Management of First line ALK-rearranged NSCLC - Part VIII
3.
Evolution in Treatment and Diagnosis of Lung Cancer- An Initiative from Manipal Hospitals
4.
Molecular Contrast: EGFR Axon 19 vs. Exon 21 Mutations - Part V
5.
INO-VATE: The Long-Term Overall Survival Analysis in Iontuzumab-Treated Patients
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation